| |
著者: Alexander Davidson, Sally Slavinski, Kendra Komoto, Jennifer Rakeman, Don Weiss
雑誌名: MMWR Morb Mortal Wkly Rep. 2016 Jul 22;65(28):716-7. doi: 10.15585/mmwr.mm6528e2. Epub 2016 Jul 22.
Abstract/Text
A routine investigation by the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) identified a nonpregnant woman in her twenties who reported she had engaged in a single event of condomless vaginal intercourse with a male partner the day she returned to NYC (day 0) from travel to an area with ongoing Zika virus transmission. She had headache and abdominal cramping while in the airport awaiting return to NYC. The following day (day 1) she developed fever, fatigue, a maculopapular rash, myalgia, arthralgia, back pain, swelling of the extremities, and numbness and tingling in her hands and feet. In addition, on day 1, the woman began menses that she described as heavier than usual. On day 3 she visited her primary care provider who obtained blood and urine specimens. Zika virus RNA was detected in both serum and urine by real-time reverse transcription-polymerase chain reaction (rRT-PCR) performed at the DOHMH Public Health Laboratory using a test based on an assay developed at CDC (1). The results of serum testing for anti-Zika virus immunoglobulin M (IgM) antibody performed by the New York State Department of Health Wadsworth Center laboratory was negative using the CDC Zika IgM antibody capture enzyme-linked immunosorbent assay (Zika MAC-ELISA) (2).
PMID 27442327 MMWR Morb Mortal Wkly Rep. 2016 Jul 22;65(28):716-7. doi: 10.15585/mmwr.mm6528e2. Epub 2016 Jul 22.
|
